Bio Nordix ApS: Financial statements 2022
CVR: 35053948
Source: annual report 2022, Danish Business Authority
01/07/2021 – 30/06/2022
Bio Nordix ApS (CVR 35053948) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 718,842 and a net result of DKK 20,645 compared with DKK -17,816 the year before. That is an increase of 5.2% compared with the year before. Equity in the 2022 report amounted to DKK 360,184. The solvency ratio was 88.1%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 718,842
- Profit/Loss
- DKK 20,645
- Equity
- DKK 360,184
- Total Assets
- DKK 408,821
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 719K | 21K | 360K | 1 |
| 2021 | - | 684K | -18K | 340K | 1 |
| 2020 | - | 587K | -2K | 357K | 1 |
| 2019 | - | 767K | 131K | 488K | 1 |
| 2018 | - | 776K | 94K | 448K | 1 |
Official annual report
Keep an eye on Bio Nordix ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout Bio Nordix ApS
Bio Nordix ApS was a Danish company of the type Anpartsselskab based in Hornbæk, founded in 2013. The company has been dissolved on 16 July 2026. The company was registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The company was previously named ØRESUND ADVENTURES ApS and MOSV BIOPLASMA ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK -6,770 and a net result of DKK -451,969 compared with DKK 67,543 the year before. Equity in the 2025 report amounted to DKK -6,095.